Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 4/2022

01-04-2022 | Interventional Cardiology (SR Bailey and T Helmy, Section Editors)

Vascular Closure: the ABC’s

Authors: Sukhdeep Bhogal, Ron Waksman

Published in: Current Cardiology Reports | Issue 4/2022

Login to get access

Abstract

Purpose of Review

Vascular access and closure is a key part of endovascular procedures, and access site-related complications are an independent predictor of adverse procedural outcomes. The purpose of this review is to discuss the methods of vascular closure including manual compression, vascular closure devices (VCDs) for both arterial and venous arteriotomies, their mechanisms, and access site-related complications.

Recent Findings

Various VCDs have been approved over the last three decades. These devices have different mechanisms to achieve hemostasis and are generally categorized into active and passive approximators. Studies have largely found that they are non-inferior to manual compression.

Summary

Uncomplicated vascular closure is pertinent to avoid adverse procedure-related outcomes. The emergence of VCDs has reduced time to hemostasis, facilitating early ambulation and discharge and reducing hospitalization cost with comparable complication rate to manual compression. Nonetheless, they should be used in favorable vascular anatomy and are not intended to reduce complications.
Literature
1.
Chiang A, Gada H, Kodali SK, Lee MS, Jeremias A, Pinto DS, et al. Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: a SCAI-based survey study of US interventional cardiologists. Catheter Cardiovasc Interv. 2014;83(5):721–26.
2.
Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65(2):196–02.CrossRef
3.
Chandrasekar B, Doucet S, Bilodeau L, Crepeau J, deGuise P, Gregoire J, et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv. 2001;52(3):289–95.CrossRef
4.
Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterizationsystematic review and meta-analysis. JAMA. 2004;291(3):350–7.CrossRef
5.
Bangalore S, Bhatt DL. Femoral arterial access and closure. Circulation. 2011;124(5):e147–56.CrossRef
6.
Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44(6):1200–9.PubMed
7.
Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159(4):518–31.CrossRef
8.
Schulz-Schüpke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, et al. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA. 2014;312(19):1981–7.CrossRef
9.
Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, et al. Effectiveness of arterial closure devices for preventing complications with percutaneous coronary intervention. Circ Cardiovasc Interv. 2016;9(4):e003464.
10.
Rao SV, Kaltenbach LA, Weintraub WS, Roe MT, Brindis RG, Rumsfeld JS, et al. Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA. 2011;306(13):1461–7.CrossRef
11.
Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention. Circulation. 2011;124(23):e574–e651.
12.
Nash JE, Evans DG. The Angio-Seal™ hemostatic puncture closure device. Herz. 1999;24(8):597–606.
13.
Hvelplund A, Jeger R, Osterwalder R, Bredahl M, Madsen JK, Jensen JS, et al. The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention. EuroIntervention. 2011;7(2):234–41.CrossRef
14.
Martin JL, Pratsos A, Magargee E, Mayhew K, Pensyl C, Nunn M, et al. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv. 2008;71(1):1–5.CrossRef
15.
Nelson PR, Kracjer Z, Kansal N, Rao V, Bianchi C, Hashemi H, et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). J Vasc Surg. 2014;59(5):1181–93.CrossRef
16.
Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40(1):78–83.CrossRef
17.
Haulon S, Hassen Khodja R, Proudfoot CW, Samuels E. A systematic literature review of the efficacy and safety of the Prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures. Eur J Vasc Endovasc Surg. 2011;41(2):201–13.CrossRef
18.
Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND ii) trials. Am J Cardiol. 2000;85(7):864–69.
19.
Veasey RA, Large JK, Silberbauer J, Paul G, Taggu W, Ellery S, et al. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital–the SCOAST study. Int J Clin Pract. 2008;62(6):912–8.CrossRef
20.
Bavry AA, Raymond RE, Bhatt DL, Chambers CE, DeNardo AJ, Hermiller JB, et al. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device. J Invasive Cardiol. 2008;20(4):152–6.PubMed
21.
Wood DA, Krajcer Z, Sathananthan J, Strickman N, Metzger C, Fearon W, et al. Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device. Circ Cardiovasc Interv. 2019;12(7):e007258.
22.
•• van Wiechen Maarten P, Tchétché D, Ooms Joris F, Hokken Thijmen W, Kroon H, Ziviello F, et al. Suture- or plug-based large-bore arteriotomy closure. JACC Cardiovasc Interv. 2021;14(2):149–57. This is a recently published study comparing suture- and plug-based vascular closure devices in large-bore arteriotomy.
23.
Wong SC, Gammon R, Bachinsky W, O’Shaughnessy C, Leimbach W, Bernardo N, et al. The CLOSER trial: a multi-center study on the clinical safety and effectiveness of Closer(TM) VSS, a novel resorbable transfemoral vascular access sealing system. Catheter Cardiovasc Interv. 2017;90(5):798–805.CrossRef
24.
Hermiller JB, Leimbach W, Gammon R, Karas SP, Whitbourn RJ, Wong SC, et al. A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients. J Invasive Cardiol. 2015;27(3):129–36.PubMed
25.
Wong SC, Bachinsky W, Cambier P, Stoler R, Aji J, Rogers JH, et al. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (ensure’s vascular closure device speeds hemostasis trial). JACC Cardiovasc Interv. 2009;2(8):785–93.
26.
Kara K, Mahabadi AA, Rothe H, Müller P, Krüger J, Neubauer H, et al. Safety and effectiveness of a novel vascular closure device: a prospective study of the ExoSeal compared to the angio-seal and proGlide. J Endovasc Ther. 2014;21(6):822–28.
27.
Scheinert D, Sievert H, Turco MA, Schmidt A, Hauptmann KE, Mueller R, et al. The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx. Catheter Cardiovasc Interv. 2007;70(5):627–33.CrossRef
28.
Scott MC, Spencer HJ, Ali AT, Moursi MM, Escobar GA, Lyons LC, et al. Mynx vascular closure device in arterial endovascular procedures. Ann Vasc Surg. 2018;46:112–7.CrossRef
29.
O’Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. Circulation. 2012;126(14):1717–27.
30.
Lata K, Kaki A, Grines C, Blank N, Elder M, Schreiber T. Pre-close technique of percutaneous closure for delayed hemostasis of large-bore femoral sheaths. J Interv Cardiol. 2018;31(4):504–10.CrossRef
31.
Thawabi M, Cohen M, Wasty N. Post-close technique for arteriotomy hemostasis after Impella removal. J Invasive Cardiol. 2019;31(6):E159.PubMed
32.
Vinayakumar D, Kayakkal S, Rajasekharan S, Thottian JJ, Sankaran P, Bastian C. 24h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: an Indian experience. Indian Heart J. 2017;69(1):37–42.
33.
Nagabandi ARS, Morgan LG, Kapoor D. Use of Vascade vascular closure system for venous hemostasis. Vasc Dis Manag. 2017;14(8):E171–3.
34.
Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio David B, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures. JACC Clin Electrophysiol. 2020;6(1):111–24.
35.
Aytemir K, Canpolat U, Yorgun H, Evranos B, Kaya EB, Şahiner ML, et al. Usefulness of ‘figure-of-eight’ suture to achieve haemostasis after removal of 15-French calibre femoral venous sheath in patients undergoing cryoablation. Europace. 2016;18(10):1545–50.CrossRef
36.
Traullé S, Kubala M, Doucy A, Quenum S, Hermida J-S. Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation. Europace. 2016;18(6):815–9.CrossRef
37.
Jensen CJ, Schnur M, Lask S, Attanasio P, Gotzmann M, Kara K, et al. Feasibility of the figure-of-8-suture as venous closure in interventional electrophysiology: one strategy for all? Int J Med Sci. 2020;17(7):965–9.CrossRef
38.
Halabi M, Ratnayaka K, Faranesh AZ, Chen MY, Schenke WH, Lederman RJ. Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions: pre-clinical validation. J Am Coll Cardiol. 2013;61(16):1745–6.CrossRef
39.
Lederman RJ, Babaliaros VC, Greenbaum AB. How to perform transcaval access and closure for transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015;86(7):1242–54.CrossRef
40.
Greenbaum AB, Babaliaros VC, Chen MY, Stine AM, Rogers T, O’Neill WW, et al. Transcaval access and closure for transcatheter aortic valve replacement: a prospective investigation. J Am Coll Cardiol. 2017;69(5):511–21.CrossRef
41.
• Rogers T, Greenbaum AB, Babaliaros VC, Stine AM, Khan JM, Schenke WH, Eng MH, Paone G, Leshnower BG, Satler LF, Waksman R. Dedicated closure device for transcaval access closure: from concept to first-in-human testing. JACC Cardiovasc Interv. 2019;12(21):2198–206. The manuscript provides insights into evolving transcaval access closure devices post-transcatheter aortic valve replacement.
42.
Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009;74(1):64–73.CrossRef
43.
Marso SP, Amin AP, House JA, Kennedy KF, Spertus JA, Rao SV, et al. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. JAMA. 2010;303(21):2156–64.CrossRef
44.
Cox T, Blair L, Huntington C, Lincourt A, Sing R, Heniford BT. Systematic review of randomized controlled trials comparing manual compression to vascular closure devices for diagnostic and therapeutic arterial procedures. Surg Technol Int. 2015;27:32–44.PubMed
45.
Biancari F, D’Andrea V, Marco CD, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159(4):518–31.
46.
Robertson L, Andras A, Colgan F, Jackson R. Vascular closure devices for femoral arterial puncture site haemostasis. Cochr Datab System Rev. 2016;3:Cd009541.
47.
•• Kennedy SA, Rajan DK, Bassett P, Tan KT, Jaberi A, Mafeld S. Complication rates associated with antegrade use of vascular closure devices: a systematic review and pooled analysis J Vasc Surg. 2021;73(2)722–30.e1. This is a recent review on complication rates of vascular closure devices.
48.
Tavris DR, Wang Y, Jacobs S, Gallauresi B, Curtis J, Messenger J, et al. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. J Invasive Cardiol. 2012;24(7):328–34.PubMed
49.
Yatskar L, Selzer F, Feit F, Cohen HA, Jacobs AK, Williams DO, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv. 2007;69(7):961–66.
50.
Kent KC, Moscucci M, Mansour KA, DiMattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors, and optimal management. J Vasc Surg. 1994;20(6):905–10; discussion 10–3.
51.
Kolluri R, Fowler B, Nandish S. Vascular access complications: diagnosis and management. Curr Treat Options Cardiovasc Med. 2013;15(2):173–87.CrossRef
52.
Kelm M, Perings SM, Jax T, Lauer T, Schoebel FC, Heintzen MP, et al. Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. J Am Coll Cardiol. 2002;40(2):291–7.CrossRef
53.
Prasad A, Compton PA, Prasad A, Roesle M, Makke L, Rogers S, et al. Incidence and treatment of arterial access dissections occurring during cardiac catheterization. J Interv Cardiol. 2008;21(1):61–6.CrossRef
54.
Messina LM, Brothers TE, Wakefield TW, Zelenock GB, Lindenauer SM, Greenfield LJ, et al. Clinical characteristics and surgical management of vascular complications in patients undergoing cardiac catheterization: interventional versus diagnostic procedures. J Vasc Surg. 1991;13(5):593–600.CrossRef
55.
Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol. 1992;69(1):63–8.CrossRef
Metadata
Title
Vascular Closure: the ABC’s
Authors
Sukhdeep Bhogal
Ron Waksman
Publication date
01-04-2022
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 4/2022
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-022-01654-z

Other articles of this Issue 4/2022

Current Cardiology Reports 4/2022 Go to the issue

New Therapies for Cardiovascular Disease (AA Bavry and MR Massoomi, Section Editors)

AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review

In Memoriam

In Memory of Kanishka Ratnayaka

Peripheral Vascular Disease (WS Jones, Section Editor)

Contemporary Management of Abdominal Aortic Aneurysms

Congenital Heart Disease (RA Krasuski and G Fleming, Section Editors)

MRI-Guided Cardiac Catheterization in Congenital Heart Disease: How to Get Started

Regenerative Medicine (SM Wu, Section Editor)

Mesenchymal Stromal Cell Exosomes in Cardiac Repair

Interventional Cardiology (SR Bailey and T Helmy, Section Editors)

Current State and Future Perspectives of Artificial Intelligence for Automated Coronary Angiography Imaging Analysis in Patients with Ischemic Heart Disease

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits